Medlab Clinical to start Cannabis trial

Company News

by Jessica Ellerm


Medlab Clinical Limited (ASX:MDC) has announced it is preparing to start Australia’s first clinical trial using cannabis.

The trial will target cancer patients suffering intractable pain and will take place at Royal North Shore Hospital in Sydney.

Commencement of the trial is subject to hospital ethics approval and the granting of a trial number from the Therapeutic Goods Administration.

Medlab’s cannabis formulation will be known as Nanabis™ and will be manufactured in Melbourne.

Medlab Clinical Limited posted a net loss of $3.7 million at 30 June 2016.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.